CompanyGraph
What stands out
- Valued far above the size of its business
At a glance
- Depends onMidstream position: 6 outgoing, 8 incoming connections
- PositionP/E ratio is 252.44×, higher than 95% of its Medical Devices peers (median 27.26×)
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.17%Below 5Y avg (0.81%)
Annual Rate
CNY 0.20Paid annual
Payout Ratio
44.4%Sustainable
Last Ex-Dividend
May 29, 2026
The reported statements, read against the company's own industry.
What stands out
- Valued far above the size of its business
Financials view
Market Capitalization
7.47BCNY1.11B · vs all stocks (USD)
Trailing P/E
252.44xvs Medical Devices peers
Revenue (TTM)
404.51MCNY60.38M · vs all stocks (USD)
Profit Margin
6.85%vs Medical Devices peers
Beta
-0.2750xvs all stocks
52-Week Change
-21.65%vs all stocks
Market Capitalization
7.47BCNY1.11B · vs all stocks (USD)
Enterprise Value
7.09BCNY1.06B · vs all stocks (USD)
Trailing P/E
252.44xvs Medical Devices peers
Price to Sales (TTM)
17.84xvs Medical Devices peers
Price to Book (MRQ)
8.57xvs Medical Devices peers
Enterprise to Revenue
17.53xvs Medical Devices peers
Enterprise to EBITDA
84.71xvs Medical Devices peers
Gross Margin
62.82%vs Medical Devices peers
Profit Margin
6.85%vs Medical Devices peers
Operating Margin
14.31%vs Medical Devices peers
Return on Assets (TTM)
1.47%vs Medical Devices peers
Return on Equity (TTM)
3.37%vs Medical Devices peers
Revenue (TTM)
404.51MCNY60.38M · vs all stocks (USD)
Revenue per Share (TTM)
6.57CNYUpdated Sep 22, 2026Quarterly Revenue Growth
4.30%vs Medical Devices peers
Gross Profit (TTM)
238.66MCNY35.63M · vs all stocks (USD)
EBITDA (TTM)
83.43MCNY12.45M · vs all stocks (USD)
Net Income (TTM)
27.71MCNY4.14M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
56.70%vs Medical Devices peers
Operating Cash Flow (TTM)
86.95MCNY12.98M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
34.44MCNY5.14M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.2000CNYUpdated Sep 22, 2026Trailing Annual Dividend Yield
0.17%vs all stocks
5-Year Average Dividend Yield
0.81%vs all stocks
Payout Ratio
44.44%vs Medical Devices peers
Revenue
398.40MCNYFY2025 · Dec 31, 2025Cost of Goods Sold
165.62MCNYFY2025 · Dec 31, 2025Gross Profit
232.78MCNYFY2025 · Dec 31, 2025Operating Income
19.92MCNY2.97M · vs all stocks (USD)
Pre-tax Income
24.82MCNYFY2025 · Dec 31, 2025Income Tax Expense
1.62MCNYFY2025 · Dec 31, 2025Net Income
23.20MCNYFY2025 · Dec 31, 2025EBIT
26.97MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
83.43MCNYFY2025 · Dec 31, 2025Research & Development
47.76MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
45.33MCNYFY2025 · Dec 31, 2025Other Operating Expenses
8.45MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
455.27KCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
2.15MCNYFY2025 · Dec 31, 2025EPS (Basic)
0.3700CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.3700CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
62.70MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
62.70MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
23.20MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
24.87MCNYFY2025 · Dec 31, 2025Free Cash Flow
-25.57MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
58.69MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
23.20MCNYFY2025 · Dec 31, 2025Other Non-cash Items
6.88MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-11.41MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
6.20MCNYFY2025 · Dec 31, 2025Capital Expenditures
-50.45MCNYFY2025 · Dec 31, 2025Net Acquisitions
23.51KCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-50.42MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
115.00MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-185.00MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-20.79MCNYFY2025 · Dec 31, 2025Other Financing Charges
4.89MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-85.90MCNYFY2025 · Dec 31, 2025Shares Outstanding
63.52MSharesUpdated Sep 22, 2026Float Shares
33.73MSharesUpdated Sep 22, 2026% Held by Insiders
77.46%vs all stocks
% Held by Institutions
1.64%vs all stocks
Total Cash (MRQ)
64.86MCNY9.68M · vs all stocks (USD)
Total Cash per Share (MRQ)
1.03CNYUpdated Sep 22, 2026Total Debt (MRQ)
32.07MCNY4.79M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.0386xvs Medical Devices peers
Current Ratio (MRQ)
2.95xvs Medical Devices peers
Book Value per Share (MRQ)
13.25CNYUpdated Sep 22, 2026Total Assets
931.30MCNY139.02M · vs all stocks (USD)
Total Current Assets
235.79MCNYFY2025 · Dec 31, 2025Total Liabilities
111.30MCNYFY2025 · Dec 31, 2025Total Non-current Assets
695.51MCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
2.76MCNYFY2025 · Dec 31, 2025Total Current Liabilities
108.54MCNYFY2025 · Dec 31, 2025Cash
58.69MCNYFY2025 · Dec 31, 2025Cash Equivalents
4.65MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
63.34MCNYFY2025 · Dec 31, 2025Accounts Receivable
55.96MCNYFY2025 · Dec 31, 2025Inventory
107.08MCNYFY2025 · Dec 31, 2025Accounts Payable
14.02MCNYFY2025 · Dec 31, 2025Short-term Debt
46.24MCNYFY2025 · Dec 31, 2025Other Current Liabilities
1.31MCNYFY2025 · Dec 31, 2025Long-term Debt
1.15MCNYFY2025 · Dec 31, 2025Common Stock (Book)
63.48MCNYFY2025 · Dec 31, 2025Retained Earnings
178.55MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
820.01MCNY122.40M · vs all stocks (USD)
Treasury Stock
20.01MCNYFY2025 · Dec 31, 202552-Week Low
76.62CNYUpdated Sep 22, 202652-Week High
217.00CNYUpdated Sep 22, 202652-Week Change
-21.65%vs all stocks
Beta
-0.2750xvs all stocks
50-Day MA
95.73CNYUpdated Sep 22, 2026200-Day MA
126.23CNYUpdated Sep 22, 2026Avg 10-Day Volume
950.44KSharesUpdated Sep 22, 2026Avg 30-Day Volume
868.34KSharesUpdated Sep 22, 2026Diluted EPS (TTM)
0.4500CNYUpdated Sep 22, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
P/E ratio is 252.44×, higher than 95% of its Medical Devices peers (median 27.26×)Significant
P/E ratio: 252.444Industry median: 27.26Industry P95: 90.04Peers compared: 60.00
Structural Tensions
Valued far above the size of its businessSignificant
Price-to-Sales: 17.84Revenue Growth YoY: 0.04
High gross margins eroded by operating costsNotable
Gross Margin: 0.63Profit Margin: 0.07
Supply Chain
Midstream position: 6 outgoing, 8 incoming connectionsNotable
Outgoing: 6.00Incoming: 8.00
High connectivity hub: 14 industry connectionsNotable
Total Connections: 14.00
Companies that share the same coordination system — how they create, deliver, or capture value.
Seegene, Inc.
Tier 1ProductionApproval-Gated PipelineRule
Amphastar Pharmaceuticals Inc.
Tier 1ProductionApproval-Gated PipelineRule
Jiuzhitang Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Guangzhou Wondfo Biotech Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
BioGaia AB
Tier 1ProductionApproval-Gated PipelineRuleFlow
Beijing Wandong Medical Technology Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Artivion Inc.
Tier 1ProductionApproval-Gated PipelineRule
Viyash Scientific Limited
Tier 1ProductionApproval-Gated PipelineRuleFlow
Shinva Medical Instrument Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Changchun BCHT Biotechnology Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule